Financial Performance - Total revenue for the year ended October 31, 2024, was 866,946,adecreaseof2892,076 in 2023 [252]. - Gross profit for 2024 was 315,946,downfrom336,162 in 2023, reflecting a gross margin of approximately 36.4% [252]. - Operating income decreased to 221,518in2024from253,050 in 2023, indicating a decline of about 12.5% [252]. - Net income attributable to Photronics, Inc. shareholders was 130,688for2024,comparedto125,485 in 2023, representing an increase of 2% [252]. - Comprehensive income for 2024 was 192,397,downfrom205,246 in 2023, indicating a decrease of approximately 6.5% [255]. - Net income for the year ending October 31, 2024, was 183,848,adecreasefrom199,634 in 2023, representing a decline of about 8% [260]. - Cash flows from operating activities provided 261,444in2024,downfrom302,176 in 2023, indicating a decrease of approximately 13.5% [260]. - The company reported share-based compensation expense of 13,890for2024,anincreasefrom8,001 in 2023, marking a rise of about 73.6% [260]. - Total expenses incurred for the year ended October 31, 2024, were 13,890million,asignificantincreasefrom8,001 million in 2023, representing a 73.6% year-over-year growth [370]. Assets and Liabilities - Total current assets increased to 931,062in2024,upfrom785,450 in 2023, marking a growth of approximately 18.5% [247]. - Total liabilities decreased to 231,300in2024from250,612 in 2023, a reduction of about 7.7% [247]. - Cash and cash equivalents rose to 598,485in2024,comparedto499,292 in 2023, reflecting an increase of approximately 19.9% [247]. - Property, plant, and equipment, net increased to 745.3millionasofOctober31,2024,from709.2 million as of October 31, 2023, reflecting a growth of 5.1% [324]. - The total inventory as of October 31, 2024, was 56.5million,anincreaseof13.150.0 million as of October 31, 2023 [322]. - The allowance for credit losses was 1.1millionasofOctober31,2024,comparedto1.1 million as of October 31, 2023, indicating stability in credit risk management [316]. Research and Development - Research and development expenses increased to 16,576in2024from13,654 in 2023, a rise of about 21.5% [252]. - Research and development expenses were 16.6million,13.7 million, and 18.3millionfortheyearsendedOctober31,2024,2023,and2022,respectively,indicatingayear−over−yearincreaseof21.263,567 million, a decrease from 70,312millionin2023[385].−Thecompany′sincomebeforeincometaxprovisionswas247,415 million for the year ended October 31, 2024, compared to 269,946millionin2023[382].−AsofOctober31,2024,thenetdeferredincometaxassetsincreasedto22,590 million from 21,062millioninthepreviousyear,reflectingavaluationallowancedecreaseduetoexpectedrealizabletaxbenefits[389].−Thebalanceofunrecognizedtaxbenefitsincreasedto14,720 million as of October 31, 2024, from 8,908millioninthepreviousyear,includinginterestandpenalties[395].−Thecompanyestablishedavaluationallowancefordeferredtaxassets,whichdecreasedin2024duetomanagement′sassessmentofrealizabletaxbenefits[389].InvestmentsandCapitalExpenditures−Thecompanyinvested130,942 in property, plant, and equipment in 2024, slightly down from 131,295in2023[260].−Thecompanyhasunrecognizedcommitmentstotaling74,046 million for the fiscal year 2025, primarily for property, plant, and equipment acquisitions [407]. - The company plans to exercise early buyout options for finance leases during the first half of 2025, which includes a 7.2millioninspectiontoolanda35.5 million lithography tool [341][342]. Share-Based Compensation - The company granted 865,050 restricted stock awards in 2024, with a weighted-average grant-date fair value of 29.50pershare,comparedto791,925awardsin2023at16.84 [373]. - The total intrinsic value of options exercised in 2024 was 2,981million,anincreasefrom1,654 million in 2023 [378]. - The company recognized $1.2 million of incremental stock-based compensation due to the accelerated vesting of restricted stock awards for departing executives [370]. - Share-based compensation expenses increased in 2024, reflecting the company's ongoing commitment to incentivizing its workforce [368].